| Pharmaceutical Formulations Manufacturing | Production of tablets, capsules, dry syrups, sachets, and semi-solid formulations | WHO GMP and USFDA approved facilities, strong global client relationships, and focused R&D capabilities | B2B global pharmaceutical companies and distributors in regulated and emerging markets | Regulated market exports and contract manufacturing | 760 | 94 | Product sales and contract manufacturing revenue | Direct sales and long-term supply contracts with fixed and negotiated pricing | USFDA approval, entry into regulated markets, new product launches, and strategic partnerships | VAGID and others |
| Domestic Pharmaceutical Sales | Sales of pharmaceutical products within India | Established domestic market presence and trusted product quality | B2B and B2C segments in India | Branded generics and niche therapeutic categories | 49 | 6 | Direct product sales through distributors and pharmacies | Market-driven pricing, with some regulated price controls | Increasing domestic demand and regulatory approvals | Various generic formulations |
